Eye tech company snags first-ever approval for spray to dilate pupils for diagnostic exams
Eye technology company Eyenovia snagged its first ever FDA approval Monday with the green light for Mydcombi, which the company calls the first approved ophthalmic spray for mydriasis, or dilated pupils.
Mydcombi, a spray made up of tropicamide and phenylephrine hydrochloride, is designed to dilate the pupil in order to make eye exams more efficient and to help keep pupils dilated during cataract surgery. Eyenovia says it’s also the first fixed-dose combination of tropicamide and phenylephrine in the United States.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.